CMS is facing growing bipartisan pressure from Congress to back off its proposal to remove Medicare Part D protected status for three drug classes, leaving some health care experts to speculate the administration might scrap this portion of its controversial Part D rule while leaving other pieces of the proposal intact. On Wednesday (March 5), House Energy & Commerce and Ways & Means GOP leaders spearheaded a bipartisan letter from nearly 50 lawmakers calling for that segment of the rule...